RESMED INC. DL-,004/ US7611521078 /
2024-05-31 8:55:23 PM | Chg. -4.25 | Volume | Bid10:00:02 PM | Ask10:00:02 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
189.25EUR | -2.20% | 210 Turnover: 39,939 |
189.60Bid Size: 52 | 190.70Ask Size: 52 | 27.95 bill.EUR | - | - |
GlobeNewswire
05-23
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provid...
GlobeNewswire
05-16
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and ...
GlobeNewswire
05-16
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Dat...
GlobeNewswire
05-07
XEALTH AND STEL LIFE TEAM UP, CONNECTING PATIENT HEALTH DEVICES AND CARE TEAMS VIA CELLULAR NETWORKS
GlobeNewswire
04-10
CHILDREN’S WISCONSIN REMOTELY MONITORING PEDIATRIC PATIENTS VIA XEALTH AND LOCUS HEALTH
GlobeNewswire
03-06
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Per...
GlobeNewswire
03-05
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
GlobeNewswire
02-15
ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communi...
GlobeNewswire
02-12
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions abo...
GlobeNewswire
02-06
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth...